Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR)
Authors:
- Sam DavidoffSDSam Davidoff
- Rakesh D. ShahRSRakesh D. Shah
- Talwar ArunabhTATalwar Arunabh
- 1 April 2006
- journal article
- case report
- Published by Elsevier in Respiratory Medicine
- Vol. 100 (4) , 760-763
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessmentAnnals of Oncology, 2004
- Severe Pulmonary Toxicity in Patients With Advanced-Stage Hodgkin's Disease Treated With a Modified Bleomycin, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, and Gemcitabine (BEACOPP) Regimen Is Probably Related to the Combination of Gemcitabine and Bleomycin: A Report of the German Hodgkin's Lymphoma Study GroupJournal of Clinical Oncology, 2004
- Amiodarone pulmonary toxicityClinics in Chest Medicine, 2004
- Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?The Annals of Thoracic Surgery, 2004
- An Autopsy Case of Acute Pulmonary Toxicity Associated with GemcitabineInternal Medicine, 2003
- A Report on Serious Pulmonary Toxicity Associated with Gemcitabine-Based TherapyInvestigational New Drugs, 2002
- Gemcitabine-Induced Pulmonary ToxicityAmerican Journal of Clinical Oncology, 2002
- Noncardiogenic Pulmonary Edema: An Unusual and Serious Complication of Anticancer TherapyThe Oncologist, 2001
- Severe acute lung injury induced by gemcitabineThe Netherlands Journal of Medicine, 2000
- Diffuse alveolar damage in a patient treated with gemcitabineEuropean Respiratory Journal, 1998